| 31st week of 2013 patent applcation highlights part 52 |
| Patent application number | Title | Published |
|---|
| 20130197066 | COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS - The present invention provides compositions methods for treating susceptible viral infections, especially hepatitis C viral (HCV) infections as well as co infections of HCV with other viruses such as HBV and/or HIV. In one embodiment, the present invention provides compositions having the formula (I) and their use in treating viral infections: | 2013-08-01 |
| 20130197067 | NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES - Provided herein are neuroprotective molecules containing a sequence of 25-35 contiguous nucleotides that is at least 80% identical to a contiguous sequence between nucleotide 1 and nucleotide 50 of a mature human tRNA and at least four contiguous guanosine-containing nucleotides, where the sequence of 25-35 contiguous nucleotides contains a D-loop stem structure, the at least four contiguous guanosine-containing nucleotides are located at the 5′ end of the neuroprotective molecule, and the neuroprotective molecule contains at least one deoxyribonucleotide. Also provided are molecules containing a sequence of 25-35 contiguous nucleotides that is at least 80% identical to a contiguous sequence between nucleotide 1 and nucleotide 50 of a mature human tRNA selected from the group of tRA | 2013-08-01 |
| 20130197068 | RNA Containing Modified Nucleosides and Methods of Use Thereof - This invention provides RNA, oligoribonucleotide, and polyribonucleotide molecules comprising pseudouridine or a modified nucleoside, gene therapy vectors comprising same, methods of synthesizing same, and methods for gene replacement, gene therapy, gene transcription silencing, and the delivery of therapeutic proteins to tissue in vivo, comprising the molecules. The present invention also provides methods of reducing the immunogenicity of RNA, oligoribonucleotide, and polyribonucleotide molecules. | 2013-08-01 |
| 20130197069 | METHODS FOR TREATING STRESS INDUCED EMOTIONAL DISORDERS - The invention relates to methods and products for treating emotional disorders such as stress induced emotional disorders, as well as related assays and kits. Methods include administering to a subject an effective amount of an agent for targeting the Rac1, Cdk5, p35, PAK-1 pathway to treat the emotional disorder. The agent for targeting the Rac1, Cdk5, p35, PAK-1 pathway may be, for instance, a Rac-1 inhibitor, a Cdk5 inhibitor, a PAK-1 activator, or p35 mobilizing agent. | 2013-08-01 |
| 20130197070 | AXL RECEPTOR TYROSINE KINASE APTAMER INHIBITOR FOR USE IN THERAPY - The present invention concerns a nucleotide aptamer having the sequence: 5′-AUGAUCAAUCGCCUCAAUUCGACAGGAGGCUCAC-3′(SEQ ID NO: 1) for use in the treatment and/or prevention and/or diagnosis of an Axl receptor tyrosine kinase induced disorder and a pharmaceutical composition comprising the same. The invention also relates to a method for the diagnosis of an Axl receptor tyrosine kinase induced disorder in a patient from which a sample is obtained and related diagnostic kit. | 2013-08-01 |
| 20130197071 | PRODUCTION OF LIPOXYGENASE INHIBITORS VIA FUNGAL BIOSYNTHETIC PATHWAY - The invention provides methods for producing lipoxygenase inhibitors including the steps set forth in Schemes 2 and 3, and uses of the inhibitors produced by the methods set forth herein in to treat various disease states. | 2013-08-01 |
| 20130197072 | METHOD FOR MANUFACTURING NEURAMINIC ACID DERIVATIVES - Methods for manufacturing neuraminic acid compounds and synthetic intermediates of neuraminic acid compounds, including a method for manufacturing a compound represented by | 2013-08-01 |
| 20130197073 | HYPOCHOLESTEROLEMIC, ANTI-INFLAMMATORY AND ANTIEPILEPTIC NEUROPROTECTIVE COMPOUND - The present invention describes a compound of formula (I) | 2013-08-01 |
| 20130197074 | USE OF ADRENERGIC BETA-3-RECEPTOR AGONISTS IN ANTI-AGING - A method for treating an aging-related disease is disclosed comprising administering to a subject a pharmaceutical composition comprising an adrenergic beta-3-receptor agonist. | 2013-08-01 |
| 20130197075 | Method of treating acquired perforating dermatosis with cantharidin - A method of treating acquired perforating dermatosis. The method has the step of applying an amount of cantharidin to an area of skin in need of treatment thereof. | 2013-08-01 |
| 20130197076 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS - Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm. | 2013-08-01 |
| 20130197077 | Bicyclic Furanones with Low Toxicity for Microbial Control - A class of bicyclic brominated furanone structures that have reduced toxicity and high activity for inhibiting biofilm formation and quorum sensing by microbes. The molecules have two fused cyclic alkyl groups that provide a structural framework that retain one or more bromine groups on the structure. The bicyclic furanones have reduced toxicity to mammalian cells as compared to other brominated furanones but retain the ability to inhibit biofilm formation in bacterial populations. | 2013-08-01 |
| 20130197078 | Crystalline Solids of a METAP-2 Inhibitor and Methods of Making and Using Same - The disclosure is in part directed to crystalline forms of 6-O-(4-dimethylaminoethoxy)cinnamoyl fumagillol and variants thereof. | 2013-08-01 |
| 20130197079 | MGLU 2/3 AGONISTS - The present invention provides novel mGlu2/3 agonists useful in the treatment of neurological or psychiatric disorders. | 2013-08-01 |
| 20130197080 | USE OF TERIFLUNOMIDE FOR TREATING MULTIPLE SCLEROSIS - This invention relates to use of teriflunomide for treating Multiple Sclerosis (MS) and managing the risks associated with the use of teriflunomide. | 2013-08-01 |
| 20130197081 | INTRAVAGINAL ADMINISTRATION OF MISOPROSTOL - A method for decreasing likelihood of cesarean section delivery in a female in need thereof, comprises administering, intravaginally, to said female, misoprostol. | 2013-08-01 |
| 20130197082 | SHORT SYNTHESIS OF TOLTERODINE, INTERMEDIATES AND METABOLITES - A process is described for the preparation of intermediates which can be used for preparation of agents for urinary incontinence therapy, specifically to 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol and its prodrugs. | 2013-08-01 |
| 20130197083 | EFFICIENT LIPID DELIVERY TO HUMAN TEAR FILM USING A SALT-SENSITIVE EMULSION SYSTEM - Provided herein are low salt ophthalmic pharmaceutical composition and methods of use thereof, for example, in the treatment of dry eye syndrome. | 2013-08-01 |
| 20130197084 | NUTRIENT SENSOR - The present invention includes compositions and methods for treating the effects of catabolism in a patient by providing the patient with an amount of an odd-chain fatty acid sufficient to increase the intracellular ratio of AMP to ATP and reduce the activity of AMPK. | 2013-08-01 |
| 20130197085 | AGENT AND METHOD FOR STABILIZING MEMBRANE PROTEIN - [Problems to be Solved] It is an object of the present invention to provide an agent and a method for maintaining and promoting the stability of a membrane protein, and in particular, a transporter (for example, an ABC transporter) on a cell membrane. | 2013-08-01 |
| 20130197086 | PROCEDURE FOR THE OBTAINMENT OF FATTY ACIDS OF PHARMACOLOGICAL AND NUTRITIONAL INTEREST - This invention refers to a procedure for obtaining fatty acids of pharmacological and nutritional interest that comprises the steps of feeding a gas comprising CO | 2013-08-01 |
| 20130197087 | COMPOSITION COMPRISING A COMBINATION OF DHA AND EPA FOR ADMINISTRATION PRIOR TO COMMENCEMENT OF CHEMOTHERAPY - The invention relates to a composition comprising a combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The composition can be used for enhancing the activity of chemotherapy or radiotherapy and/or in the prevention or reduction of side effects caused by the chemotherapy or radiotherapy in a patient ill with cancer, the composition being intended for administration to the patient prior to the commencement of a cycle of chemotherapy or radiotherapy. | 2013-08-01 |
| 20130197088 | Compositions and Methods for Combinations of Oligoamines with 2-Difluoromethylornithine (DFMO) - The present invention is based on the seminal discovery of a synergistic effect for combinations of oligoamines with 2-difluoromethylornithine (DFMO) for treatment of cancer. The invention provides combinations of at least one inhibitor of a histone demethylase enzyme and at least one inhibitor of ornithine decarboxylase (ODC). The invention also provides methods for treatment of cancer using such combinations and methods for altering methylation in a cell using such combinations. The invention provides that certain silenced genes can be re-expressed using combinations disclosed herein. | 2013-08-01 |
| 20130197089 | COMPOSITIONS FOR THE TREATMENT OF ACTINIC KERATOSIS - Ibuprofen can be used in the prevention and treatment of actinic keratosis. | 2013-08-01 |
| 20130197090 | POSTURAL STABILITY AND INCIDENT FUNCTIONS IN PATIENTS - The present invention provides methods and systems for reducing falls in patients that are recurrent fallers. Specifically, the compositions, systems, and methods can relate to Parkinson's disease patients, particularly such patients that are suffering from neurogenic orthostatic hypotension. The compositions, systems, and methods comprise the use of droxidopa, optionally in combination with a further active agent. Administration of droxidopa has been found to reduce the mean number of falls per patient per week, as well as provide improvements in the patient's Hoehn and Yahr rating scale score, which is indicative of improvements in postural stability, and provide improvements in the patient's Unified Parkinson's disease Rating Scale score, which is indicative of improvements in the severity of motor and/or non-motor symptoms of Parkinson's disease. | 2013-08-01 |
| 20130197091 | USE OF ADRENERGIC BETA-E-RECEPTOR BLOCKERS IN CANCER TREATMENT - A method for treating an cancer disease is disclosed comprising administering to a subject a pharmaceutical composition comprising an adrenergic beta-3-receptor blocker. | 2013-08-01 |
| 20130197092 | Novel Non-Aqueous Topical Solution of Diclofenac and Process for Preparing the Same - A novel non-aqueous topical solution composition of pharmaceutically acceptable salt of diclofenac is disclosed. The non-aqueous topical solution composition comprises therapeutically effective amount of pharmaceutically acceptable salt of diclofenac, solublizer, penetration enhancer and solvent, and optionally a humectant, counter irritant, additional penetration enhancer and anti-oxidants and a process for preparing the same. | 2013-08-01 |
| 20130197093 | ENHANCED BIMATOPROST OPHTHALMIC SOLUTION - A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein. | 2013-08-01 |
| 20130197094 | TRPV1 COMPOUNDS IN A BIODEGRADABLE POLYMER CARRIER - Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of a TRPV1 compound (e.g., capsaicinoid compound) at or near a target site, one can relieve pain caused by diverse sources, including but not limited to, postoperative pain, spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days. | 2013-08-01 |
| 20130197095 | SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES - The invention relates to compounds that have an affinity to the μ-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions. | 2013-08-01 |
| 20130197096 | ALKOXY COMPOUNDS FOR DISEASE TREATMENT - The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are alkoxyl derivative compounds and pharmaceutical compositions comprising these compounds. The subject compositions are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease. | 2013-08-01 |
| 20130197097 | NOVEL SPIROENONE AND USES THEREOF - The present invention provides novel spiroenones extracted from an alcohol extract of dehulled adlay seeds. The present invention also provides a process for the preparation of the spiroenones and a method for treating breast cancer in a subject, which method comprises administering to said subject an effective amount of the spiroenone and a pharmaceutically acceptable carrier or excipient. | 2013-08-01 |
| 20130197098 | COMPOSITION IN FORM OF A GEL FOR THE VIRUCIDAL DISINFECTION OF MAMMALIAN SKIN - The present invention describes a composition in form of a gel for the virucidal disinfection of mammalian skin comprising 71 to 95 weight percent of a C1 to C3 monoalcohol, 0.01 to 1 weight percent thickener and wherein the composition has a viscosity range of from 3000 to 19000 mPas measured at 20° C. with spindle LV3 at a speed of 2.5 rpm. Furthermore, the invention describes a method for virucidal disinfection of skin. | 2013-08-01 |
| 20130197099 | PARTIALLY ABSORBABLE FIBER-REINFORCED COMPOSITES FOR CONTROLLED DRUG DELIVERY - This invention describes a partially absorbable, fiber-reinforced composite in the form of a ring, or a suture-like thread, with modified terminals for use as a controlled delivery system of at least one bioactive agent, wherein said composite comprising an absorbable fiber construct capable of providing time-dependent mechanical properties of a biostable elastomeric matrix containing an absorbable microparticulate ion-exchanger to modulate the release of the bioactive agent(s) for a desired period(s) of time at a specific biological site; this can be a vaginal canal, peritoneal cavity, scrotum, prostate gland, an ear loop or subcutaneous tissue. Such drug delivery systems can be used for the local administration of at least one bioactive agent, including those used as contraceptive, antimicrobial, anti-inflammatory and/or antiviral agents as well as for cancer treatment. | 2013-08-01 |
| 20130197100 | COLLOIDAL NANOSCALE CARRIERS FOR ACTIVE HYDROPHILIC SUBSTANCES AND METHOD FOR PRODUCING SAME - The invention “colloidal nanoscale carriers for active hydrophilic substances and method for producing same” pertains to the field of medical, odontological or hygiene preparations, and is characterized by structures formed by hydrophilic polymers that contain active hydrophilic substances coated with a non-hydrophilic phase and surfactants with affinity for the components, forming an invert emulsion that allows the incorporation and controlled delivery of active hydrophilic substances, conferring properties such as protection against degradation processes, improvement of compatibility with the other components of the formulation in the final product, increase in the availability and/or bioavailability of the active substance in the medium of interest (including improvements in permeation processes in biological materials, reduction of the exposure and volatilization of the active substance in the medium) and controlled release of the active substance(s). The nanoscale carrier obtained by this method, called colloidal nanoscale carrier (NC), can be used in various fields, such as the pharmaceutical field (including dermatology), cosmetics, personal hygiene products, veterinary medicine, agrochemicals and fertilizers, the food industry and the like. The invention proposes a kinetically stable system with an effective nanoscale structure that consists of nanoscale carriers formed by polymers emulsified in a non-aqueous medium in the presence of a surfactant with affinity for the two phases (the dispersion medium and the encapsulating agent). This system is obtained by nanoemulsification of an aqueous phase of hydrophilic polymers emulsified in a non-hydrophilic (lipophilic or silophilic) phase that contains the surfactants, and is characterized by the implementation of two concepts that encompass the generation of an invert nanoscale emulsion and of polymer nanoparticles. The formulation has the novel technical effect of providing a polymer excipient with a nanoscale structure for delivering hydrophilic molecules suspended in a non-hydrophilic phase, which allows controlling the size of the nanoscale particles and modulating colloidal stability by means of process parameters. | 2013-08-01 |
| 20130197101 | NOVEL ELECTROLYTE-RESISTANT CATIONIC THICKENERS USABLE OVER A WIDE PH RANGE, METHOD FOR PREPARING SAME, AND COMPOSITION CONTAINING SAME - Positive latex including a straight, branched, or cross-linked cationic polyelectrolyte from the polymerization, in molar %, of: a molar ratio ≧70% and ≦99% of monomer units from at least one cationic monomer; b) a non-zero molar ratio <20% of monomer units from N-(2-hydroxyethyl)acrylamide; c) a non-zero molar ratio ≦15% of monomer units from at least one monomer of formula (I): A-C(=0)-0-[(CH | 2013-08-01 |
| 20130197102 | 3D MATRICES OF HUMAN ELASTIN-LIKE POLIPEPTIDES AND METHOD OF PREPARATION THEREOF - 3D matrices or hydrogels made of human elastin-like polypeptides and their preparation are described. Said matrices can be obtained by enzymatic cross-linking of such polypeptides and can be used in the biomedical and pharmaceutical fields as support the growth of cells, isolated or as multicellular association, both on the surface and inside the matrix. Said matrices can also deliver pharmacologically active molecules, which are incorporated and then released in a controlled manner. | 2013-08-01 |
| 20130197103 | COMPOSITION AND METHOD FOR THE ENHANCEMENT OF THE EFFICACY OF DRUGS - The present invention relates to the enhancement of the efficacy of drugs, and more particularly, with overcoming the resistance of cells or organisms to drugs. In particular, the present invention provides a method for enhancing the effectiveness of a cytotoxic or anti-neoplastic agent, comprising the step of co-administering said agent with hyaluronan, wherein co-administration with hyaluronan enhances the agent's cancer cell-killing potential. | 2013-08-01 |
| 20130197104 | REDUCED SUGAR SYRUPS AND METHODS OF MAKING REDUCED SUGAR SYRUPS - A reduced sugar syrup having an advantageously low viscosity is prepared by hydrolysis of starch or starchy material using a particular type of alpha amylase enzyme which yields a saccharide distribution having a low DP1-2 and low DP11+ content. The DP4 content of the syrup may be favorably increased by using a maltotetragenic alpha amylase enzyme in combination with the aforementioned alpha amylase enzyme. The syrup is useful in the production of food, beverage, animal feed, animal health and nutrition, pharmaceutical, and cosmetic compositions and may be combined with a high intensity sweetener to provide a composition capable of being substituted for conventional corn syrups. | 2013-08-01 |
| 20130197105 | DPI FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN - An inhalable dry powder formulation containing SAE-CD and an active agent is provided. The formulation is adapted for administration by DPI. The SAE-CD serves as a carrier rather than as an absorption enhancer. The average particle size of the SAE-CD is large enough to preclude (for the most part) pulmonary deposition thereof. Following release from the DPI device, the SAE-CD-containing particles dissociate from the active agent-containing particles in the buccal cavity or throat, after which the active agent-containing particles continue deeper into the respiratory tract. The physicochemical and morphological properties of the SAE-CD are easily modified to permit optimization of active agent and carrier interactions. Drugs having a positive, neutral or negative electrostatic charge can be delivered by DPI when SAE-CD is used as a carrier. | 2013-08-01 |
| 20130197106 | METHODS OF IDENTIFYING A CANDIDATE COMPOUND - The invention relates to methods identifying compounds for the treatment of cell proliferation-related disorders, e.g., proliferative disorders such as cancer. | 2013-08-01 |
| 20130197107 | METHOD FOR PRODUCTION OF STABLE CERIUM OXIDE ORGANIC COLLOIDS - An improved process for producing substantially non-polar doped or un-doped cerium oxide nanoparticle dispersions is disclosed. The cerium-containing oxide nanoparticles of an aqueous colloid are transferred to a substantially non-polar liquid comprising one or more amphiphilic materials, one or more low-polarity solvents, and one or more glycol ether promoter materials. The transfer is achieved by mixing the aqueous and substantially non-polar materials, forming an emulsion, followed by a phase separation into a remnant polar solution phase and a substantially non-polar organic colloid phase. The organic colloid phase is then collected. The promoter functions to speed the transfer of nanoparticles to the low-polarity phase. The promoter accelerates the phase separation, and also provides improved colloidal stability of the final substantially non-polar colloidal dispersion. Importantly, the glycol ether promoter reduces the temperature necessary to achieve the phase separation, while providing high extraction yield of nanoparticles into the low-polarity organic phase. | 2013-08-01 |
| 20130197108 | SILOXANE POLYETHER COPOLYMERS - The present invention is related to the preparation and use of moderately cross-linked (chin-extended), reverse (or “inverted”) surfactants, wherein the reverse surfactants comprise a polyether backbone with oligomeric or polymeric silicon-containing substitutions along the backbone. The present invention further describes crosslinked versions of the inverted surfactants, reaction products of alkenyl (allyl, vinyl, methallyl) functional copolymers (polyethers), silicone hydrides and cross-linking agents, which may be optionally reacted with water to react the remaining alkoxy groups. The crosslinking agent contains either SiH or Si-alkoxy groups or both. The compounds of the present invention exhibit only moderate cross-linking in order to be soluble or dispersible in appropriate solvents. | 2013-08-01 |
| 20130197109 | SUSPENDED-SLURRY REACTOR - An apparatus for generating a large volume of gas from a liquid stream is disclosed. The apparatus includes a first channel through which the liquid stream passes. The apparatus also includes a layer of catalyst particles suspended in a solid slurry for generating gas from the liquid stream. The apparatus further includes a second channel through which a mixture of converted liquid and generated gas passes. A heat exchange channel heats the liquid stream. A wicking structure located in the second channel separates the gas generated from the converted liquid. | 2013-08-01 |
| 20130197110 | SULPHUR-CONTAINING AND SULPHONATED AROMATIC PERFLUOROALKANE MONOMER - A sulphur-containing and sulphonated aromatic perfluoroalkane monomer is provided that can be used for the manufacture of a polymer membrane for a PEM-type fuel cell. The perfluoroalkane monomer is a functionalized polymer that has a structure corresponding to a formula (I): | 2013-08-01 |
| 20130197111 | ANTIMICROBIAL POLYMER COMPOSITIONS AND THE USE THEREOF - An antimicrobial composition comprising an ionic complex of an anionic polyester with an antimicrobial metal, wherein the anionic polyester has an ion exchange capacity from about 0.19 meq/g to about 1.0 meq/g. | 2013-08-01 |
| 20130197112 | Process for Producing Expanded Polyolefin Resin Particles and Expanded Polyolefin Resin Particles - Process for producing expanded polyolefin resin particles with use as a foaming agent in water contained in an aqueous dispersion medium. The process includes dispersing polyolefin resin particles with use as a foaming agent of water contained in an aqueous dispersion medium. The process includes dispersing polyolefin resin particles together with the aqueous dispersion medium into a closed vessel, heating the polyolefin resin particles up to or above a softening temperature of the polyolefin resin particles and pressurizing the polyolefin resin particles, and releasing the polyolefin resin particles into a zone whose pressure is lower than an internal pressure of the closed vessel. The polyolefin resin particles are composed of a polyolefin resin composition including a polyolefin resin, polyethylene glycol homopolymer and a foam nucleating agent. | 2013-08-01 |
| 20130197113 | POLYURETHANE FOAM COMPOSITIONS AND PROCESS FOR MAKING SAME - The present invention generally relates to polyurethane foam composition. In one embodiment, the present invention relates to polyurethane foam compositions that have increased and/or improved fire-retardant properties due to the inclusion of one or more liquid and/or solid fire-retardants. In another embodiment, the present invention relates to polyurethane foam compositions that have increased and/or improved fire-retardant properties due to the inclusion of one or more intumescent materials (e.g., expandable graphite (EG)). In still another embodiment, the present invention relates to polyurethane foam compositions that have increased and/or improved fire-retardant properties due to the inclusion of expandable graphite. | 2013-08-01 |
| 20130197114 | Process For Producing Flexible Polyurethane Foam Using Natural Oil Polyols - A composition and process useful to make flexible polyurethane foams and in particular flexible molded polyurethane foams is disclosed. The usage of dipolar aprotic liquids such as DMSO, DMI, sulfolane, N-methyl-acetoacetamide, N,N-dimethylacetoacetamide as well as glycols containing hydroxyl numbers OH#≦1100 as cell opening aides for 2-cyanoacetamide or other similar molecules containing active methylene or methine groups to make a polyurethane foam is also disclosed. The advantage of using cell opener aids results in a) no foam shrinkage; b) lower use levels of cell opener; c) foam performance reproducibility d) optimum physical properties. In addition, combining the acid blocked amine catalyst together with the cell opener and the cell opener aid results in a less corrosive mixture as well as provides a method that does not require mechanical crushing for cell opening. | 2013-08-01 |
| 20130197115 | HFO/WATER-BLOWN RIGID FOAM SYSTEMS - The present invention relates to a process for producing rigid polyurethane foams by reaction of a) at least one organic polyisocyanate with b) at least one polyol component in the presence of a blowing agent mixture comprising water and halogenated alkenes, wherein the amount of water is at least 1.40 mol/kg of polyol component b) and the amount of halogenated alkene is at most 2.00 mol/kg of polyol component b), and also to the use of such a blowing agent mixture for producing corresponding rigid polyurethane foams and for increasing the adherence and reducing the thermal conductivity of corresponding rigid polyurethane foams. The present invention further relates to a rigid polyurethane foam obtainable by the process of the present invention. | 2013-08-01 |
| 20130197116 | Ultra High Strength Chalk Based Composition - Disclosed herein are ultra high strength compositions, such as comprising, in parts by weight: from about 20% to about 30% plastic; from about 55% to about 65% calcium carbonate; and from about 10% to about 20% fiber. Further disclosed is an ultra high strength composition, comprising, in parts by weight: from about 31% to about 39% plastic; from about 40% to about 50% calcium carbonate and from about 15% to about 25% fiber to which a foaming agent is added. | 2013-08-01 |
| 20130197117 | LINKER AND SUPPORT FOR SOLID PHASE SYNTHESIS OF NUCLEIC ACID - The invention provides a universal linker capable of synthesizing nucleic acid having a hydroxy group at the 3′ terminal, a universal support carrying the linker, and a synthesis method of nucleic acid using the universal support. The linker contains a compound represented by the formula | 2013-08-01 |
| 20130197118 | LOW-DENSITY POLYURETHANE SHOE SOLES OR SOLE PARTS WITH HIGH REBOUND RESILIENCE AND LOW COMPRESSION SET - A process for producing a polyurethane shoe sole having an article density of 100 to 350 g/L and being made from an organic polyisocyanate, a polyol, a blowing agent consisting of water, and optionally a crosslinking and/or chain-extending agent, a catalyst, and other auxiliaries and/or additives. First, polyisocyanate, polyol and any crosslinking and/or chain-extending agent are mixed and reacted at a temperature of 110° C. to 180° C. to give a prepolymer having polyisocyanate groups. Second, the isocyanate-terminated prepolymer obtained and any remaining polyisocyanate are mixed with any remaining polyol, blowing agent comprising water, and any remaining crosslinking and/or chain-extending agent and also any catalyst and other auxiliaries and/or additives are introduced into a mold and allowed to fully react to give a polyurethane shoe sole. | 2013-08-01 |
| 20130197119 | MICROCELLULAR FOAM MOLDING OF AIRCRAFT INTERIOR COMPONENTS - An article comprising: a monolithic, single layer, rigid thermoplastic interior component for an aircraft, wherein the thermoplastic interior component has a microcellular foam structure, wherein the thermoplastic interior component has an average two minute heat release of less than or equal to 65 kw-min/m | 2013-08-01 |
| 20130197120 | HIGHLY CRYSTALLINE POLYETHYLENE - The present invention relates to methods for making highly crystalline polymeric material, for example, highly crystalline cross-linked and not cross-linked ultra-high molecular weight polyethylene (UHMWPE). The invention also provides methods of making additive-doped highly crystalline polymeric material using high pressure and high temperature crystallization processes, medical implants made thereof, and materials used therein. | 2013-08-01 |
| 20130197121 | METHOD OF MAKING CROSSLINKED POLYMERIC MATERIAL FOR ORTHOPAEDIC IMPLANTS - A method for making a crosslinked polymeric material for use in an orthopaedic device is described. The method may include the use of one or more crosslinking enhancers to enhance the crosslinking process. | 2013-08-01 |
| 20130197122 | NANOCOMPOSITES WITH IMPROVED HOMOGENEITY - The present invention relates to nanocomposites comprising nanoparticles and a thermoplastic polymer composition, said nanocomposite being characterized by improved homogeneity, and in consequence by improved properties. Further, the present invention relates to a process for the production of such nanocomposites by first dispersing the nanoparticles in a dispersant and subsequent blending with a thermoplastic polymer composition. | 2013-08-01 |
| 20130197123 | DIENE-BASED CARBOXYLATE ANION AND SALT THEREOF, AND POLYMERIZABLE OR CURABLE COMPOSITION THEREOF - The claimed invention provides a novel compound not having been studied before, that is, a diene carboxylate anion that contains a specific structure, and a salt thereof. The claimed invention further provides a diene carboxylate anion and a salt thereof, especially a metal salt thereof, which are easily soluble in general organic solvents, reactive diluents, and resins, may be in a liquid state at normal temperature depending on the structure, and have high polymerizability. Polymerization/curing of these produces a resin to which many ionic bonds and a metal are introduced, providing various properties such as hardness, scratch resistance, anti-fingerprint property, gas-barrier property, water vapor barrier property, oxygen absorption property, ultraviolet protection, infrared protection, color development and coloring, high refractive index, adhesion, various catalytic abilities, fluorescence ability and light-emitting ability, optical amplification, dispersibility, and antistatic properties. In addition, the anion and the salt can be used for raw materials for functional fine particles and for metal nanoparticle composites, and also for MOD materials. The claimed invention also provides an advantageous method for producing the diene carboxylate anion and the salt thereof. | 2013-08-01 |
| 20130197124 | ADHESIVE CREAM - Improved composition of a fixing cream, in particular for tooth prostheses, containing at least one oil and/or fat, preferably of a plant type, at least one water-soluble polymer selected from the group of cellulose derivatives, at least one alkyl vinyl ether/maleic acid anhydride copolymer, | 2013-08-01 |
| 20130197125 | MONO ETHYLENICALLY UNSATURATED POLYMERIZABLE GROUP CONTAINING POLYCARBOSILOXANE MONOMERS - The present invention relates to polymeric compositions useful in the manufacture of biocompatible medical devices. More particularly, the present invention relates to certain monoethylenically unsaturated polymerizable group containing polycarbosiloxane monomers capable of polymerization to form polymeric compositions having desirable physical characteristics useful in the manufacture of ophthalmic devices. | 2013-08-01 |
| 20130197126 | Paste-Like Bone Cement - The present invention relates to a paste, a kit, and the use of the paste for mechanical fixation of articular endoprostheses. The paste contains at least one polymer for radical polymerisation, at least one polymer that is soluble in at least one monomer for radical polymerisation, and at least one filling agent that is poorly soluble or insoluble in at least one monomer for radical polymerisation, whereby the filling agent is a particulate cross-linked polymethacrylate produceable through polymerisation of methacrylic acid esters, whereby | 2013-08-01 |
| 20130197127 | COLOR-STABILIZED IODOPROPYNYL BUTYLCARBAMATE - Microparticles containing an ultraviolet light absorbing polymer and 3-iodo-2-propynyl butylcarbamate (“IPBC”) resist discoloration by sunlight and other ultraviolet light sources. Methods for preparing the microparticles produce polymer-shielded, formaldehyde-free IPBC formulations which resist discoloration and leaching, and are especially useful in water-based applications. The microparticles include a polymer that absorbs light over a range of ultraviolet wavelengths associated with IPBC discoloration. The microparticles may be utilized in paints, stains, stuccoes, adhesives, and plastics, for example. | 2013-08-01 |
| 20130197128 | METHOD AND COMPOSITION FOR ROAD CONSTRUCTION AND SURFACING - Methods and compositions for improving the strength and longevity of secondary roadways through environmentally sound practices are disclosed herein. A composition for road sealing includes an aqueous emulsion of acrylic and vinyl acetate polymer, water, and a resin-modified emulsion, wherein the resin-modified emulsion includes a mixture of pitch and rosin, an emulsifying agent, and water. | 2013-08-01 |
| 20130197129 | LIQUID EPOXY RESIN COMPOSITION AND SEMICONDUCTOR DEVICE - Disclosed is a liquid epoxy resin composition containing: (A) a liquid epoxy resin comprising at least one liquid epoxy resin represented by the following general formula (1) or (2): | 2013-08-01 |
| 20130197130 | B-STAGEABLE AND SKIP-CURABLE WAFER BACK SIDE COATING ADHESIVES - An adhesive composition comprising elastomeric polymer, epoxy resin, reactive diluent, and filler, is suitable for use within the electronics industry, and in particular for wafer back side coating adhesives. The elastomeric polymer is a mixture of a vinyl elastomer and an epoxy elastomer; the reactive diluent is a combination of two or more diluents, one of which must have carbon to carbon unsaturation, providing cross-linking within the composition after cure; and the filler is a non-conductive filler. | 2013-08-01 |
| 20130197131 | RUBBER COMPOSITION FOR TIRE, METHOD OF PRODUCING THE SAME, AND PNEUMATIC TIRE - Provided are a rubber composition for a tire, in which while the use of petroleum resources is reduced as much as possible, the compatibility of microfibrillated plant fibers with the rubber component is enhanced by a simple method, which can lead to a balanced improvement in tensile properties, handling stability, and fuel economy; a method of producing the rubber composition; and a pneumatic tire formed from the rubber composition. The rubber composition for a tire contains a rubber component; microfibrillated plant fibers; and natural shellac resin. It is preferable that the rubber component should include at least one selected from the group consisting of natural rubber, modified natural rubber, synthetic rubber, and modified synthetic rubber, and it is preferable that the microfibrillated plant fibers should be cellulose microfibrils. | 2013-08-01 |
| 20130197132 | RUBBER COMPOSITION FOR TIRE, METHOD OF PREPARING THE SAME, AND PNEUMATIC TIRE - Provided are a rubber composition for a tire, in which while the use of petroleum resources is reduced as much as possible, the compatibility of microfibrillated plant fibers with the rubber component is enhanced by a simple method, which can lead to a balanced improvement in tensile properties, handling stability, and fuel economy; a method of preparing the rubber composition; and a pneumatic tire formed from the rubber composition. The present invention relates to a rubber composition for a tire, containing a rubber component, microfibrillated plant fibers, and an industrial lignin. It is preferable that the rubber component should contain at least one selected from the group consisting of natural rubber, modified natural rubber, synthetic rubber, and modified synthetic rubber, and it is preferable that the microfibrillated plant fibers should be cellulose microfibrils. | 2013-08-01 |
| 20130197133 | Biodegradable Hydrophobic Cellulosic Substrates And Methods For Their Production Using Halosilanes - A method for rendering a substrate hydrophobic while maintaining its biodegradability includes treating the substrate with a halosilane such that the halosilane forms a silicone resin in the interstitial spaces of the substrate. The method parameters can be controlled such that the resulting hydrophobic cellulosic substrate is compostable. | 2013-08-01 |
| 20130197134 | COMPOSITIONS OF WARM MIX ASPHALT, PROCESS FOR THE SAME, USE THEREOF IN SURFACES - The present invention relates to use of organic chemical additives for the preparation of warm asphalt mixtures. The compositions of asphalt mixtures in accordance with the present invention provides a manufacturing, spreading and compaction lower temperatures up to 70° C. compared to the temperatures used in the production and application of conventional hot mix asphalt used in paving and road asphalt concrete overlays. | 2013-08-01 |
| 20130197135 | DERIVATIVES OF NATIVE LIGNIN FROM ANNUAL FIBRE FEEDSTOCKS - The present invention provides derivatives of native lignin having certain aliphatic hydroxyl content. Surprisingly, it has been found that consistent and predictable antioxidant activity may be provided by selecting for derivatives of native lignin having certain aliphatic hydroxyl content. | 2013-08-01 |
| 20130197136 | POLYOLEFIN COMPOSITION FOR WATER PIPES WITH INCREASED RESISTANCE TO CHLORINE DIOXIDE - The present invention relates to a polyolefin composition with increased resistance to degradation caused by ClO | 2013-08-01 |
| 20130197137 | PROCESS FOR PREPARING HIGH-PURITY ORGANICALLY MODIFIED PHYLLOSILICATES - The present invention relates to a novel process for preparing organically modified sheet silicates in high purity. The process of the invention uses ion exchange resins for this purpose. | 2013-08-01 |
| 20130197138 | RUBBER COMPOSITION FOR GOLF BALL - Rubber composition for golf balls which includes: (A) a base rubber containing a polybutadiene having a cis-1,4 bond content of at least 60 wt %; (B) an unsaturated carboxylic acid and/or a metal salt thereof; (C) an anthranilic acid derivative of the general formula | 2013-08-01 |
| 20130197139 | CURABLE ORGANOPOLYSIOLXANE COMPOSITION, OPTICAL DEVICE SEALING MATERIAL, AND OPTICAL DEVICE - The present invention is a curable organopolysiloxane composition containing (A) a compound shown by the following average composition formula (1), wherein R | 2013-08-01 |
| 20130197140 | ESTERS OF CYCLOHEXANE POLYCARBOXYLIC ACIDS AS PLASTICIZERS IN RUBBER COMPOUNDS - It has been discovered that the use of a plasticizer, an ester of a cyclohexanepolycarboxylic acid, especially a 1,2-cyclohexanedicarboxylic acid ester, that is environmentally non-toxic, can replace environmentally unfriendly phthalate plasticizers, such as dioctyl phthalates used in vulcanizable rubber compositions, especially for tires, on a one to one weight basis (phr) without sacrificing beneficial rubber properties. | 2013-08-01 |
| 20130197141 | CURABLE COMPOSITION HAVING COMBINED STABILIZERS - The invention aims to improve temperature resistance for a curable composition based on a silyl-terminated polymer. This is achieved by using a combination of at least two phenolic compounds, of which one is free of thioether groups, while the other contains at least one thioether group in at least one alkyl side chain. The invention further relates to the use of the curable composition as an adhesive, sealant and/or coating substance and to the use of the combination of phenolic compounds to increase the temperature stability in curable compositions. | 2013-08-01 |
| 20130197142 | PROCESS FOR THE PREPARATION OF SURFACE TREATED MINERAL FILLER PRODUCTS AND USES OF SAME - The present invention relates to a process for preparing a surface treated mineral filler product, and to its preferred use in the field of plastic applications, and in particular polypropylene (PP)-or polyethylene (PE)-based breathable or extrusion coating film applications. | 2013-08-01 |
| 20130197143 | ELASTOMERIC COMPOSITIONS - The present invention relates to a novel polyurethane, copolyether ester or copolyether amide elastomer composition comprising a glycol derived from random copolymerization of alkylene oxide and tetrahydrofuran (THF), the alkylene oxide having from 2 to 4 carbon atoms, i.e., poly(tetramethylene-co-alkyleneether)glycol. | 2013-08-01 |
| 20130197144 | INKJET INK AND INK CARTRIDGE - An inkjet ink is provided, containing: water; a water-soluble organic solvent; a colorant comprising a resin coating type colorant; and a resin emulsion comprising an anionic polyurethane resin emulsion, wherein the inkjet ink in an initial state has an average particle diameter D50(INI), and the inkjet ink in a dried state having 60% by mass of the initial state has an average particle diameter D50(60%), such that the inkjet ink satisfies the following formula: | 2013-08-01 |
| 20130197145 | THERMOPLASTIC MELT-MIXED COMPOSITION WITH POLYACID METAL SALT HEAT STABILIZER - Disclosed is a thermoplastic melt-mixed composition including a) a polyamide resin b) about 1.0 to about 5.0 weight percent of a polyacid metal salt selected from the group consisting of citrate metal salts, malate metal salts, tartarate metal salts and combinations thereof, c) 10 to 60 weight percent reinforcing agent; and, optionally, 0 to 30 weight percent polymeric toughener; and molded or extruded thermoplastic articles made therefrom. | 2013-08-01 |
| 20130197146 | PROCESS OF FORMING AN ARAMID COPOLYMER - The invention concerns processes for forming a polymer comprising residues of 2-(4-amino phenyl)-5 (6) amino phenyl benzimidazole (DAPBI), paraphenylene diamine, and terephthaloyl dichloride, comprising the steps of: a) forming a solution of DAPBI and paraphenylene diamine dihydrochloride in a solvent system comprising an organic solvent and an inorganic salt; b) cooling the solution to a temperature of 30° C. or less; c) adding a stoichiometric amount of terephthaloyl dichloride, relative to the total amount of the DAPBI and the paraphenylene diamine dihydrochloride, to the solution; and d) agitating the solution of step c) to form a polymer. | 2013-08-01 |
| 20130197147 | PROCESS FOR FORMING AN ARAMID COPOLYMER - The invention concerns processes for forming polymer crumb comprising residues of 2- (4-amino phenyl)-5 (6) amino phenyl benzimidazole (DAPBI), paraphenylene diamine (PPD), and terephthaloyl dichloride, comprising the steps of: (a) forming a slurry of b mole percent DAPBI and y mole percent PPD in a solvent system comprising organic solvent and c weight percent of an inorganic salt, wherein the inorganic salt is present in an amount of at least 5 weight percent of the organic solvent, DAPBI and PPD being present in an amount sufficient for providing a polymer solution having a weight percent solids of 12 percent or greater on a polymer basis; and (b) contacting the slurry of step a) with a stoichiometric amount of terephthaloyl dichloride to form a product comprising the polymer; wherein the sum of y+b is 100 and the product of b×c is 225 or greater. | 2013-08-01 |
| 20130197148 | PROCESS FOR FORMING AN ARAMID COPOLYMER - The invention concerns processes for forming a polymer comprising residues of 2-(4-amino phenyl)-5(6)amino phenyl benzimidazole (DAPBI), paraphenylene diamine, and terephthaloyl dichloride, the process comprising: (a) forming a solution of oligomers having chloride end groups from one mole of paraphenylene diamine and 1.3 to 5 moles of terephthaloyl dichloride a solvent system comprising an organic solvent and an inorganic salt; and (b) adding DAPBI and terephthaloyl dichloride to the solution of oligomers to form a polymer. | 2013-08-01 |
| 20130197149 | MULTIVINYL SILOXANE OLIGOMER-BASED POLYMER DISPERSIONS AND METHODS OF PREPARING AND USING THE SAME - Multivinyl siloxane oligomer-based compositions and methods for their preparation and use are described herein. The multivinyl siloxane oligomer-based compositions can be prepared as aqueous polymer dispersion. The aqueous polymer dispersions can include water and a polymer derived from at least one multivinyl siloxane oligomer having an Si—O—Si backbone and at least one alkoxy group and one or more additional monomers. Further described herein are products including the aqueous polymer dispersions and methods for their preparation and use. | 2013-08-01 |
| 20130197150 | Stain-resistant articles - The present invention relates to stain- or dye-resistant light colored articles comprising a polymer composition (C) comprising a semi-aromatic polyamide comprising recurring units resulting from the condensation of terephthalic acid, isophthalic acid and at least one aliphatic diamine comprising 6 carbon atoms, a filler and from 0.1 to 35 wt. % of a white pigment, based on the total weight of the polymer composition (C). | 2013-08-01 |
| 20130197151 | Process for Preparing Amine-Modified Polyester Resins with Improved Melt Flow - The invention is directed to a process for preparing a linear or branched amine-modified thermoplastic resin with high flowability using as starting materials a linear or branched polyester and a primary or secondary aliphatic amine. The process does not require that the amine and polyester be combined in a liquid organic solvent during the process, and can be performed readily at ambient pressure. The amine-modified resins can be extruded and pelletized using normal operating conditions, making this process a versatile option for achieving a wide variety of viscosities in a simple, low cost, continuous operation. | 2013-08-01 |
| 20130197152 | POLYESTER RESINS BASED ON FATTY ACIDS THAT HAVE A SHORT OIL LENGTH, AQUEOUS DISPERSIONS AND ASSOCIATED COATINGS - The invention relates to a polyester resin which is based on at least one fatty acid, with a zero oil length (0%) or an oil length of between 0 and 35%, with a weight ratio of oxidizable fatty acids (monoacids), relative to the overall fatty acids, of 0 or greater than 0 and ranging up to 1, and which is based on an acid component comprising, in addition to said fatty acid, from 30% to 85% by weight, relative to the total weight of said resin, of rosin and/or of derivatives thereof bearing at least one carboxylic acid function. | 2013-08-01 |
| 20130197153 | HETEROPHASIC POLYPROPYLENE WITH HIGH FLOWABILITY AND ENHANCED MECHANICAL PROPERTIES - The present invention relates to a heterophasic polypropylene resin comprising a crystalline propylene homopolymer matrix (A) and an amorphous propylene copolymer phase (B) dispersed within the matrix having excellent mechanical properties, in particular at low temperatures, and at the same time high flowability. Further, the invention relates to a production process of the heterophasic polypropylene resin, the use of such a resin in a polypropylene composition and to articles made of the heterophasic polypropylene resin. | 2013-08-01 |
| 20130197154 | MODIFIED POLYVINYL ALCOHOL, MODIFIED POLYVINYL ACETAL AND CERAMIC SLURRY COMPOSITION - The present invention provides a modified polyvinyl alcohol enabling to produce polyvinyl acetal that is excellent in solubility in a solvent even with a low degree of polymerization while hardly causing reaction inhibition, coloring, and particle coarsening, and a method for producing the modified polyvinyl alcohol. The present invention also provides a modified polyvinyl acetal that is excellent in solubility in a solvent even with a low degree of polymerization, and has high elasticity, mechanical strength, and a film forming property. The present invention further provides a method for producing the modified polyvinyl acetal, a polyvinyl acetal film produced from the modified polyvinyl acetal, a method for producing the polyvinyl acetal film, a ceramic slurry composition, a method for producing the ceramic slurry composition, and a ceramic green sheet. The present invention is a modified polyvinyl alcohol including at least one functional group selected from the group consisting of hydroxyl, aldehyde, carboxyl, and lactone ring groups at a molecular end, and having a degree of saponification of 99.95 mol % or higher and a 1,2-glycol bond content of 1.4 mol % or lower. | 2013-08-01 |
| 20130197155 | AQUEOUS COATING COMPOSITION, AND TWO-PACK TYPE CURABLE AQUEOUS COATING KIT - An aqueous coating composition, which comprises water and particles that have an average particle size of from 50 to 100 nm and are made of a fluorinated copolymer (A) having from 40 to 60 mol % of fluoroolefin polymerized units (a1), from 1 to 5 mol % of polymerized units (a2) having carboxy groups in which from 95 to 100 mol % of the carboxy groups are changed into carboxylate groups, from 4 to 30 mol % of polymerized units (a3) having crosslinking groups other than carboxy groups, and from 3 to 50 mol % of polymerized units (a4) having a group containing an ether bond or ester bond in its side chain, based on the total amount of polymerized units contained in the copolymer, and which is characterized by having a pH of from 7.0 to 9.5. | 2013-08-01 |
| 20130197156 | BLOCK-COPOLYMER CONTAINING CROSSLINKABLE PHOTOINITATOR GROUPS - A block-copolymer containing at least two different blocks wherein block A contains (meth)acrylate monomers the copolymer having a glass transition temperature of less than 15° C., block B contains (meth)acrylate monomers the copolymer having a glass transition temperature of more than 25° C. being free of thio-containing substances in the polymer chain, characterized in that one block contains at least one photoinitiator chemically bound to the chain. | 2013-08-01 |
| 20130197157 | COPOLYMER OF CONJUGATED DIENE COMPOUND AND NON-CONJUGATED OLEFIN, RUBBER COMPOSITION, CROSS-LINKED RUBBER COMPOSITION AND TIRE - In a copolymer of a conjugated diene compound and a non-conjugated olefin, the conjugated diene unit has a cis-1,4 bond content of greater than 70.5% and the non-conjugated olefin is contained in an amount of 10 mol % or more. | 2013-08-01 |
| 20130197158 | SELF-ALIGNED GRAPHENE POLYMER NANOCOMPOSITES - Highly-oriented graphene polymer nanocomposites are produced from an aqueous dispersion of graphene oxide in polyurethane latex followed by chemical reduction to form graphene sheets. | 2013-08-01 |
| 20130197159 | POLYURETHANE ELASTOMER COATINGS - Embodiments of the invention provide for coatings which include the reaction product of a reaction system, where the reaction system encompasses at least one prepolymer having isocyanate functional groups, where the prepolymer includes the reaction product of at least one isocyanate and at least one polyol having an hydroxyl functionality of between about 2 and about 6. a sodium silicate solution, at least one isocyanate reactive component having at least one of a hydroxyl and an amine functionality of between about 2 and about 4, at least one intumescent filler, at least one filler, and optionally a suspension agent. | 2013-08-01 |
| 20130197160 | COPOLYMER SYNTHESIZED FROM A MODIFIED GLYCOSAMINOGLYCAN (GAG) AND AN ANHYDRIDE FUNCTIONALIZED HYDROPHOBIC POLYMER - A new copolymer synthesized from a glycosaminoglycan (GAG) such as hyaluronan/hyaluronic acid (HA), chondroitin sulfates, derma tan sulfates, keratan sulfates, heparan sulfate, and heparin, and an anhydride functionalized hydrophobic polymer, i.e., any polyolefin which has been ‘functionalized’ (grafted onto the backbone or incorporated into the backbone) with anhydride functional groups, such as maleic anhydride-graft-polyethylene, (or, maleated polyethylene), maleic anhydride-graft-polystyrene, maleic anhydride-graft-polypropylene, etc. The functionalized polyolefin may be a polyolefin backbone to which the anhydride functional groups have been grafted, or otherwise incorporated with the backbone. Also, a unique synthesis technique combines a modified GAG with a graft polyolefin, resulting in a unique copolymer with its constituents by-and-large covalently bound to each other. | 2013-08-01 |
| 20130197161 | Injection Molded Article Comprising Polypropylene and Polylactic Acid - A film comprising a polylactic acid and polypropylene blend having a haze of from about 10% to about 95% and a gloss 45° of from about 50 to about 125. A method of producing an oriented film comprising blending polypropylene and polylactic acid to form a polymeric blend, forming the polymeric blend into a film, and orienting the film. A method of producing an injection molded article comprising blending polypropylene and polylactic acid to form a polymeric blend, injecting the polymeric blend into a mold, and forming the article. | 2013-08-01 |
| 20130197162 | INTERCONNECTION BETWEEN CONDUCTING POLYMER MATERIALS - Method for connecting two portions of a first electrically conducting polymer with a second polymer. The method includes disposing a solution of a second polymer in a solvent to be in contact with the two portions of the first electrically conducting polymer and allowing the solvent to evaporate leaving the second polymer joining the two portions of the first polymer. The second polymer may be doped to improve its conductivity. | 2013-08-01 |
| 20130197163 | Fluoroelastomers - The invention pertains to peroxide-curable fluoroelastomers for the oil and gas industry, including explosive decompression, and which can be easily processed to yield cured parts in standard machineries at reasonable throughput rates, said fluoroelastomers comprising:
| 2013-08-01 |
| 20130197164 | MACROMONOMERS FOR PREPARATION OF DEGRADABLE POLYMERS AND MODEL NETWORKS - The present invention relates to methods for preparing degradable model networks from any monomer functionality with any degradation methodology. It is based on the use of Atom-Transfer Radical Polymerization and CLICK chemistry to form the desired product. | 2013-08-01 |
| 20130197165 | METHOD OF PRODUCING LIQUID CRYSTAL POLYESTER - A method is provided of producing a liquid crystal polyester, including: preparing a liquid crystal polyester prepolymer containing a repeating unit represented by general formula (1) and a repeating unit represented by general formula (2) by melt polymerization, cooling and solidifying the prepolymer to obtain a solidified prepolymer, pulverizing the solidified prepolymer to obtain a prepolymer powder, and heating the prepolymer powder to conduct solid-phase polymerization. A liquid crystal polyester is thereby prepared having a polymerization degree higher than the prepolymer. Preparing a liquid crystal polyester is performed with a rate of temperature rise within a temperature range of from a temperature 10° C. lower than a final end-point temperature of the solid-phase polymerization to the final end-point temperature of from 0.01° C./min to 0.03° C./min. | 2013-08-01 |
